Applied Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
DEFA14A: Applied Therapeutics Seeks Stockholder Approval for Reverse Stock Split and Executive Compensation
Applied Therapeutics is holding its annual meeting on June 9, 2025, seeking stockholder votes on director election, auditor ratification, executive compensation, and a reverse stock split.
Applied Therapeutics is asking stockholders to approve a reverse stock split at its annual meeting on June 9, 2025, to regain compliance with Nasdaq listing requirements.
Applied Therapeutics, Inc. has filed a definitive proxy statement with the U.S. Securities and Exchange Commission.
Applied Therapeutics is holding its annual stockholder meeting on June 6, 2024, to vote on director elections, auditor ratification, an increase in authorized shares, and other matters.